Literature DB >> 31551605

Trials take MS treatment forward.

Ian Fyfe1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31551605     DOI： 10.1038/s41582-019-0271-4

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis.

Authors:  Kjetil Bjornevik; Kassandra L Munger; Marianna Cortese; Christian Barro; Brian C Healy; David W Niebuhr; Ann I Scher; Jens Kuhle; Alberto Ascherio
Journal:  JAMA Neurol       Date:  2020-01-01       Impact factor: 18.302
  1 in total
  1 in total

Review 1.  The potential of serum neurofilament as biomarker for multiple sclerosis.

Authors:  Stefan Bittner; Jiwon Oh; Eva Kubala Havrdová; Mar Tintoré; Frauke Zipp
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.